Dianthus Therapeutics reported 3.8 in PE Price to Earnings for its fiscal quarter ending in September of 2024.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Celltrion 41.5 17.47 Jun/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 84.22 25.87 Sep/2026
IQVIA Holdings 29.03 7.58 Sep/2026
Kangmei Pharma 1.11K 0 Jun/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 15.55 3.54 Jun/2026
Organon & Co 17.56 3 Sep/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 24.29 7.94 Sep/2026
Qiagen NV 23.09 6.37 Sep/2026
Revvity 56.86 20.39 Sep/2026
Sartorius 47.29 5.7 Sep/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 468.91 434.44 Sep/2026
Xeris Pharmaceuticals 92.28 16.23 Jun/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 39.33 3.06 Sep/2026